BPS - ADVANCE THE DEVELOPMENT OF V920, A VACCINE AGAINST EBOLA VIRUS USING A RECOMBINANT VESICULAR STOMATITIS VIRUS VECTOR. IGF::OT::IGF
$65,103,309
| Recipient | MERCK SHARP & DOHME LLC UEI FCFDA78HKKG2 |
|---|---|
| Award ID | HHSO100201600031C |
| Award amount | $65,103,309 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response |
| NAICS | 541711 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY |
| PSC | AN13 |
| Set-aside | Unrestricted |
| Start date | Aug 29, 2016 |
| End date | Sep 30, 2024 |
| Place of performance | AMES, IA |
| Record updated | Sep 4, 2025 |
View the official award record
More awards won by MERCK SHARP & DOHME LLC
COVID-19 ORAL ANTIVIRAL MK-4482 (MOLNUPIRAVIR)
Department of Defense · $2,205,000,834 · Jun 7, 2021
IGF::OT::IGF
Department of Health and Human Services · $236,307,634 · Sep 28, 2017
ERVEBO PROCUREMENT
Department of Health and Human Services · $156,033,983 · Sep 30, 2024
ADDRESSING THE COVID-19 PANDEMIC: URGENT PRIORITIES
Department of Health and Human Services · $102,299,549 · Mar 1, 2021
VACCINE STORAGE AND ROTATION, 2021-2026
Department of Health and Human Services · $6,426,702 · Sep 16, 2021
Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.
Search open bids